Cabot (NYSE:CBT) Sets New 12-Month High – Here’s Why

Cabot Corporation (NYSE:CBTGet Free Report)’s share price reached a new 52-week high on Tuesday . The stock traded as high as $90.07 and last traded at $89.0090, with a volume of 16849 shares changing hands. The stock had previously closed at $89.21.

Wall Street Analyst Weigh In

Several research analysts have commented on the company. UBS Group lifted their price target on Cabot from $81.00 to $86.00 and gave the stock a “neutral” rating in a research report on Friday, May 8th. Wall Street Zen raised shares of Cabot from a “hold” rating to a “buy” rating in a report on Sunday. JPMorgan Chase & Co. raised their price target on Cabot from $68.00 to $70.00 and gave the stock an “underweight” rating in a report on Wednesday, May 13th. Mizuho boosted their target price on Cabot from $75.00 to $80.00 and gave the company a “neutral” rating in a report on Wednesday, May 6th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a research note on Tuesday, May 26th. Two investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Cabot presently has a consensus rating of “Hold” and an average price target of $83.80.

Get Our Latest Stock Analysis on Cabot

Cabot Stock Performance

The stock’s fifty day simple moving average is $80.36 and its 200-day simple moving average is $74.12. The company has a quick ratio of 0.96, a current ratio of 1.45 and a debt-to-equity ratio of 0.51. The company has a market capitalization of $4.60 billion, a PE ratio of 16.90, a PEG ratio of 11.53 and a beta of 0.82.

Cabot (NYSE:CBTGet Free Report) last announced its quarterly earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 EPS for the quarter, topping the consensus estimate of $1.47 by $0.14. The business had revenue of $904.00 million for the quarter, compared to analyst estimates of $900.31 million. Cabot had a return on equity of 21.33% and a net margin of 7.97%.The company’s quarterly revenue was down 3.4% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.90 EPS. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. On average, research analysts predict that Cabot Corporation will post 6.34 earnings per share for the current fiscal year.

Cabot Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, June 12th. Investors of record on Friday, May 29th were given a $0.4725 dividend. The ex-dividend date was Friday, May 29th. This represents a $1.89 annualized dividend and a dividend yield of 2.1%. This is a boost from Cabot’s previous quarterly dividend of $0.45. Cabot’s payout ratio is presently 35.73%.

Hedge Funds Weigh In On Cabot

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Smartleaf Asset Management LLC lifted its holdings in shares of Cabot by 598.0% in the third quarter. Smartleaf Asset Management LLC now owns 349 shares of the specialty chemicals company’s stock valued at $27,000 after purchasing an additional 299 shares in the last quarter. Torren Management LLC acquired a new position in shares of Cabot during the 4th quarter worth approximately $26,000. Rothschild Investment LLC lifted its stake in Cabot by 170.4% in the 4th quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company’s stock valued at $27,000 after buying an additional 259 shares in the last quarter. Geneos Wealth Management Inc. lifted its stake in Cabot by 409.0% in the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock valued at $38,000 after buying an additional 364 shares in the last quarter. Finally, Global Retirement Partners LLC grew its holdings in Cabot by 1,606.9% during the 4th quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock valued at $33,000 after buying an additional 466 shares during the last quarter. Institutional investors and hedge funds own 93.18% of the company’s stock.

About Cabot

(Get Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

Featured Stories

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.